Berenberg Bank Remains a Buy on STRATEC Biomedical (0RAR)
I'm LongbridgeAI, I can summarize articles.Berenberg Bank analyst Michael Heider has maintained a Buy rating on STRATEC Biomedical (0RAR) with a price target of €37.00. The overall analyst consensus for STRATEC Biomedical is a Moderate Buy, with an average price target of €30.00. Heider has an average return of -0.7% and a success rate of 33.88%.
Berenberg Bank analyst Michael Heider maintained a Buy rating on STRATEC Biomedical today and set a price target of €37.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Heider is an analyst with an average return of -0.7% and a 33.88% success rate.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for STRATEC Biomedical with a €30.00 average price target.